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Edited by Gianni CesareniAbstract LDOC1 was isolated as a gene encoding a leucine-
zipper protein whose expression was decreased in pancreatic
and gastric cancer cell lines in 1999. Here, we found that over-
expression of LDOC1 caused externalization of the cell
membrane phosphatidylserine, which was characteristic for
early-phase apoptotic events, and reduced cell viability in some
human cell lines. The apoptotic process was triggered by a loss
of the mitochondrial membrane potential, leading to both
caspase-3-dependent and -independent pathways. Furthermore,
a transcription factor, MZF-1, was revealed to interact with
LDOC1 and enhance the activity of LDOC1 for inducing
apoptosis.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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MZF-1; Cancer1. Introduction
LDOC1 was ﬁrst identiﬁed as a gene whose expression
was decreased in a series of pancreatic and gastric cancer
cell lines by Nagasaki et al. [1] using an RNA diﬀerential
display technique in 1999, but its precise functions remain
to be clariﬁed.
On the other hand, we revealed that MZF-1, a hematopoi-
etic transcription factor regulating the diﬀerentiation and pro-
liferation of myeloid cells [2–5], repressed the expression of
human high aﬃnity IgE receptor (FceRI) b-chain via an intro-
nic element [6]. In the course of a study to elucidate mecha-
nisms by which MZF-1 regulates the FceRI b-chain gene
expression, we screened a human cDNA library for MZF-1-
interacting proteins and identiﬁed LDOC1 as a candidate. Be-
cause its overexpression in some cell lines reduced cell viability,
we further investigated functions of this molecule in details.
Recently, Nagasaki et al. [7] also reported that LDOC1 en-
hanced the antiproliferation activity of TNF-a and PMA in
a pancreatic cancer cell line, BxPC-3. In this study, we demon-Abbreviations: FBS, fetal bovine serum; AD, activation domain; BD,
binding domain; PS, phosphatidylserine; Ade, adenine
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doi:10.1016/j.febslet.2004.12.030strate that LDOC1 directly induces apoptosis in some human
cell lines by cooperating with MZF-1.2. Materials and methods
2.1. Cell culture
Cells were cultured in a humidiﬁed incubator with 5% CO2 at 37 C.
Jurkat (a human T cell line) and K562 (a human chronic myelogenous
leukemia cell line) were cultured in RPMI1640 medium (Sigma, St.
Louis, MO). HeLa (a human epithelial cell line) was cultured in Dul-
beccos modiﬁed Eagles medium (Sigma). All media contained 10% fe-
tal bovine serum (FBS) (JRH Bioscience, Lenexa, KS), 100 U/ml of
penicillin, and 100 lg/ml of streptomycin.
2.2. Plasmid construction
The plasmid pACT2-LDOC1 carrying a full-length LDOC1 cDNA
fused to the GAL4 activation domain (AD) was obtained by yeast two
hybrid screening using MZF-1 fused to the GAL4 binding domain
(BD) as bait [8]. LDOC1 cDNA prepared by digestion of pACT2-
LDOC1 with EcoRI/XhoI was inserted into the vector pCR3.1 (Invit-
rogen Corp., Carlsbad, CA) at the EcoRI/XhoI site to construct
pCR3.1-LDOC1. A NdeI/XhoI-digested fragment from pACT2-
LDOC1 was inserted at the NdeI/XhoI site of pGADT7 (BD Biosci-
ences Clontech, Palo Alto, CA) to obtain pGADT7-LDOC1. MZF-1
expression plasmids, pGBKT7-MZF1, and pCR3.1-hMZF1sense,
were constructed as previously described [6,8]. An empty vector,
named pCR3.1-self, was generated by self-ligation of EcoRI-digested
pCR3.1 and used as a control.
2.3. Transfection of the cells
Cells were washed with medium containing 20% FBS and then resus-
pended in the same medium at a concentration of 1 · 107 cells/500 ll.
The cells were transfected with various amounts (2.5–10 lg) of
pCR3.1-LDOC1 or pCR3.1-self by electroporation at 300 V, 950 lF
using Gene Pulser II (Bio-Rad, Hercules, CA). For cotransfection as-
say, pCR3.1-LDOC1 (0.5 and 1.5 lg) and pCR3.1-hMZF1sense (5 lg)
were cointroduced similarly.
2.4. Detection of externalization of plasma membrane phosphatidylserine
Phosphatidylserine (PS) translocated from the inner to the outer
leaﬂet of the plasma membrane was detected 8 h after the transfection
with pCR3.1-LDOC1 or pCR3.1-self (as a control) by Annexin V-
FITC Apoptosis Detection Kit I (BD Pharmingen, San Diego, CA)
following the manufacturers instructions. Flow cytometric analyses
were performed with FACSCaliber (Becton–Dickinson, Franklin
Lakes, NJ).
2.5. Evaluation of mitochondrial membrane potential
Cells were stained with JC-1 (Molecular Probe, Eugene, OR) 8 h
after the transfection and observed under a FLUOVIEW 300 confocal
microscope (Olympus, Tokyo, Japan) using an oil immersion
40·objective.blished by Elsevier B.V. All rights reserved.
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Cells were harvested 14 h after the transfection of pCR3.1-LDOC1
to measure the enzymatic activity of caspase-3 with a CaspACE Assay
System (Promega, Madison, WI). EOS9.1, a monoclonal antibody
against Fas (CD95) (eBioscience, San Diego, CA), was used for a po-
sitive control to induce apoptosis at a concentration of 10 lg/ml.
2.7. Yeast two-hybrid assay
Yeast AH109 was cotransformed with pGBKT7-MZF1 and
pACT2-LDOC1 as recommended by the manufacturer of MATCH-
MAKER GAL4 Two-Hybrid System 3 (BD Biosciences Clontech).
pGBKT7-53, pGADT7-T and pGBKT7-Lam encoding murine p53
(a.a. 72–390), SV40 large T antigen and human lamin c (a.a. 65–
230), respectively, were all obtained from BD Biosciences Clontech
and used as controls. Protein interactions were detected by the expres-
sion of the HIS3 and ADE2 reporter genes under the control of dis-
tinct GAL4 upstream activating sequences and TATA boxes.
2.8. Immunoprecipitation of in vitro transcription/translation products
c-Myc-tagged MZF-1, c-Myc-tagged lamin c, and HA-tagged
LDOC1 were prepared by in vitro transcription/translation employing
a TNT T7 Quick Coupled Transcription/Translation System (Promega)
with 1 lg of pGBKT7-MZF1, pGBKT7-Lam or pGADT7-LDOC1,
respectively. Each translated protein and the mixtures of the products
were subjected to immunoprecipitation with anti-c-Myc polyclonal Ab
(Santa Cruz, Santa Cruz, CA) followed by blotting with anti-c-Myc
(Santa Cruz) and anti-HA (Roche, Basel, Switzerland) mAbs.1
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Fig. 2. Introduction of LDOC1 induces apoptosis in Jutkat cells in a
dose and time dependent manner. Various amounts (2.5, 5.0, and
10 lg) of pCR3.1-LDOC1 or the empty vector pCR3.1-self were
introduced into Jurkat cells. The number of viable cells was determined
with trypan blue dye exclusion tests at the indicated time points after
the transfection. Closed circles, pCR3.1-LDOC1 2.5 lg; closed
squares, pCR3.1-LDOC1 5.0 lg; closed triangles, pCR3.1-LDOC1
10 lg; open circles, pCR3.1-self; open squares, pCR3.1-self 5.0 lg;
open triangles, pCR3.1-self 10 lg.3. Results
3.1. LDOC1 directly induces apoptosis in some human cell lines
Three human tumor cell lines were transfected with an
expression plasmid of LDOC1 and tested for their viability
by trypan blue dye exclusion tests (Fig. 1). Overexpression of
LDOC1 decreased the number of viable cells to one half of
the control in Jurkat and K562 cells, but had little eﬀect in
HeLa cells, indicating that LDOC1 directly reduced the cell
viability in some cell lines. Transfection experiments with en-
hanced green ﬂuorescent protein (EGFP) revealed that the
transfection eﬃciency was similar between Jurkat and K562
cells and slightly higher in HeLa cells (data not shown). We
examined kinetics for viable cells of Jurkat transfected withJurkat K562 Hela
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Fig. 1. Overexpression of LDOC1 induces apoptosis in some human
cell lines. Human tumor cell lines, Jurkat, K562, and HeLa, were
transfected with 5 lg of an LDOC1 expression plasmid, pCR3.1-
LDOC1. After 16 h of incubation, the number of viable cells was
determined with trypan blue dye exclusion tests. Values are ratios of
viable cells to those of transfectants with the equivalent amount of an
empty vector, pCR3.1-self. Results are expressed as means ± S.D. of
eight independent experiments.LDOC1. As represented in Fig. 2, from about 6 to 8 h after
the transfection, viable cells gradually decreased in a manner
dependent on the amount of LDOC1 expression plasmid (ﬁlled
symbols). In contrast, introduction of the empty vector had al-
most no eﬀects (open symbols).
We next detected externalization of plasma membrane PS
observed in the cells undergoing apoptosis by Annexin V stain-
ing. In Fig. 3, Annexin-V-FITC positive and propidium ino-
dide (PI)-negative cells in the early phase of apoptosis (right
lower panels) were increased by LDOC1 overexpression in a
manner dependent on the dose of expression plasmid com-
pared with mock transfection. The results thereby indicated
that the LDOC1-induced cell death was due to apoptosis. Both
increase of dead cells (Annexin-V-FITC/ PI double positive
cells, right upper panels) and decrease of viable cells (Ann-Fig. 3. Introduction of LDOC1 in Jurkat cells dose-dependently
induces externalization of plasma membrane phosphatidylserine.
Jurkat cells were transfected with pCR3.1-LDOC1 (2.5 lg (B), 5 lg
(C), and 10 lg (D)) or 10 lg of the empty vector pCR3.1-self (A) and
cultured for 8 h. Cells were stained with Annexin V-FITC and PI to be
analyzed by ﬂow cytometry. Values are percentages of the cells
distributed in each fraction.
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Fig. 5. LDOC1-induced apoptosis is partially dependent on caspase-3.
Jurkat cells were transfected with 5 lg of pCR3.1-LDOC1 or the
equivalent amount of the empty vector. Anti-Fas (CD95) mAb EOS9.1
was employed for a positive control to induce apoptosis at a
concentration of 10 lg/ml. (A) Cells were harvested after 14 h of
culture to measure the caspase-3 activity. Results are expressed as
means ± S.D. of three independent experiments. (B) Cells were
cultured with or without 50 lM of Z-VAD-FMK, a pan-caspase-3-
speciﬁc inhibitor, for 16 h. Viable cell numbers were determined with
trypan blue dye exclusion tests. In LDOC1 transfection, viable cell
numbers relative to those in the mock transfection are represented. In
EOS.9.1 treatment, viable cell numbers relative to those without
606 M. Inoue et al. / FEBS Letters 579 (2005) 604–608exin-V-FITC/PI double negative cells, left lower panels) were
thought to be due to apoptosis.
3.2. LDOC1-induced apoptosis is triggered by a loss of
mitochondrial membrane potential with/without caspase
activation
To examine apoptotic pathways induced by LDOC1, we
analyzed the mitochondrial membrane potential (DW) by JC-
1 staining. DW was decreased in the cells transfected with
LDOC1 (A) but not with the empty vector (B), indicating that
LDOC1-induced apoptosis was triggered by the loss of DW
(Fig. 4). The loss of DW is known to cause the release of mito-
chondrial intermembrane proteins including cytochrome c,
which is responsible for activation of caspases [9,10], in addi-
tion to other molecules involved in caspase-independent apop-
tosis such as AIF [11–14], HtrA2/Omi [15,16] and
Endonuclease-G [17]. Caspase-3 activity was remarkably in-
creased by the LDOC1 transfection, compared with the mock
transfection in Jurkat cells (Fig. 5A). On the other hand, Z-
VAD-FMK, a speciﬁc inhibitor of pan-capase, only partially
recovered the LDOC1-transfected cells from apoptosis, while
it almost completely inhibited the cell death induced by anti-
FAS Ab (Fig. 5B). Collectively, these results indicated that
LDOC1-induced apoptosis was partially dependent on cas-
pase-3. It was therefore speculated that the loss of DW caused
by LDOC1 led to release of mitochondrial intermembrane pro-
teins working in both caspase-dependent and -independent
fashions.
3.3. MZF-1 interacted with LDOC1 and enhanced activity of
LDOC1 for inducing apoptosis
Screening for MZF-1-interacting proteins with yeast two-
hybrid assay [8] identiﬁed LDOC1 as a candidate protein. To
verify the interaction between LDOC1 and MZF-1, the expres-Fig. 4. LDOC1 induces a loss of the mitochondrial membrane
potential. Jurkat cells were transfected with 5 lg of pCR3.1-LDOC1
(A) or the equivalent amount of the empty vector pCR3.1-self (B).
After 8 h of culture, cells were stained with JC-1 and observed under a
confocal microscope. JC-1 probe forms red-ﬂuorescent aggregates
under normal mitochondrial membrane potential, whereas it exists as a
green-ﬂuorescent monomer under low mitochondrial membrane
potential.
EOS.9.1 are shown. Results are expressed as means ± S.D. of three
independent experiments.sion plasmid for MZF-1 fused to GAL4BD and that for
LDOC1 fused to GAL4 AD were cointroduced into yeast
AH109 cells. The transformant was tested for expression of
the HIS3 and ADE2 reporter genes on the basis of its nutri-
tional requirements (Fig. 6A). The yeast cells expressing BD-
MZF-1 and AD-LDOC1 grew on -His/-Ade medium, indicat-
ing that BD-MZF-1 bound AD-LDOC1. In contrast, the cells
expressing BD-MZF-1/AD alone or BD-lamin c/AD-LDOC1
did not grow on the medium. We conﬁrmed the MZF-1/
LDOC1 interaction by immunoprecipitation of in vitro trans-
lated proteins. c-Myc-tagged BD-MZF-1 and HA-tagged AD-
LDOC1 were translated in vitro and mixed together. Immuno-
precipitation with anti-c-Myc Ab revealed coprecipitation of
LDOC1 (Fig. 6B, lane 3). In contrast, LDOC1 was not copre-
cipitated together with lamin c (lane 4). Immunoprecipitation
of single protein translation product revealed that c-Myc-
BD-MZF-1 (lane 1) but not HA-AD-LDOC1 (lane 2) was pre-
cipitated, indicating that HA-AD-LDOC1 did not bind anti-c-
Myc Ab-conjugated protein G-agarose non-speciﬁcally. Be-
cause all of these results showed actual interaction between
MZF-1 and LDOC1, we next investigated the eﬀects of
MZF-1 coexpression in Jurkat cells into which small amounts
of LDOC1 expression plasmid were introduced (Fig. 6C).
When compared with mock transfection (dotted bars), apopto-
Fig. 6. MZF-1 interacts with LDOC1 and enhances its apoptosis-
inducing activity. (A) Yeast AH109 was cotransformed with
GAL4BD-MZF-1 and GAL4AD-LDOC1. The transformant was
tested for growth on -His/-Ade medium to examine the expression of
HIS3 and ADE2 reporter genes. Expression plasmids for GAL4AD,
GAL4BD-lamin c (GAL4BD-Lam), GAL4BD-p53 (GAL4BD-53),
and GAL4AD-SV 40 large T antigen (GAL4AD-T) were used as
controls. (B) c-Myc-tagged BD-MZF-1, c-Myc-tagged BD-lamin c,
and HA-tagged AD-LDOC1 were, respectively, prepared by in vitro
transcription/translation. The translated products were mixed and
incubated for 20 min at room temperature. Then, the mixtures (c-Myc-
BD-MZF-1/HA-AD-LDOC1 (lane 3) and c-Myc-BD-lamin c/HA-
AD-LDOC1 (lane 4)) were subjected to immunoprecipitation with
anti-c-Myc Ab followed by blotting with anti-c-Myc and anti-HA
mAbs. Similarly, c-Myc-BD-MZF-1 (lane 1) and HA-AD-LDOC1
(lane 2) were, respectively, incubated for 20 min and immunoprecip-
itated with anti-c-Myc Ab as controls. (C) Jurkat cells were transfected
with 0, 0.5 or 1.5 lg of pCR3.1-LDOC1 in the presence or absence of
MZF-1. After 16 h of incubation, viable cell numbers were determined
with trypan blue dye exclusion tests. Viable cell numbers relative to
those in the transfectants with the equivalent amounts of an empty
vector in the absence of MZF-1 are represented. Results are expressed
as means ± S.D. of three independent experiments.
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but not induced by 0.5 lg of LDOC1 plasmid (hatched bars).
In both cases, induction of cell death was enhanced by MZF-1
cotransfection (ﬁlled bars). On the other hand, results of mock/
MZF-1 cotransfection (opened bars) indicated that MZF-1 it-
self did not induce cell death. It was thus revealed that MZF-1
bound to LDOC1 and enhanced activity of LDOC1 for induc-
ing apoptosis.4. Discussion
LDOC1 has characteristic domains; a leucine-zipper like
motif at the N-terminal, a proline-rich region containing a
Src homology 3 (SH3)-binding motif, and an acidic region at
the C-terminal. The interaction of LDOC1 with MZF-1 might
be mediated by the leucine-zipper and/or proline-rich region,
because these motifs often mediate protein–protein interaction.
Although LDOC1 itself lacks a nuclear localization signal, it
was reported to localize to the nucleus [1], raising the possibil-
ity that LDOC1 distributes in the nucleus by forming a com-
plex with MZF-1. In addition, because LDOC1 possesses an
SH3-binding site, it is possible that Src kinase activated
through a speciﬁc stimulation phosphorylates LDOC1 and en-
ables it to bind MZF-1 and localize to the nucleus. Interest-
ingly, MZF-1 itself was reported to inhibit apoptosis in
several cell lines [18–20] and enhance the expression of Bcl-2
[18]. The apoptosis-inducing activity of LDOC1 may be partly
due to inhibition of this anti-apoptotic eﬀect of MZF-1. Since
HeLa cells express signiﬁcantly lower level of MZF-1 than
other cell lines [6], overexpressed LDOC1 should eﬃciently in-
hibit the anti-apoptotic activity of MZF-1 and therefore in-
duce apoptosis. However, overexpression of LDOC1 in
HeLa cells poorly induced apoptotic cell death (Fig. 1), indi-
cating the existence of other pathways by which the LDOC1/
MZF-1 complex actively induces apoptosis. Little amount of
LDOC1/MZF-1 complex in HeLa cells probably led to poor
induction of apoptosis.
Both our results and those of Nagasaki et al. [1,7] suggest
that LDOC1 is a candidate for a diagnostic marker of cancer.
More detailed analyses will reveal the precise mechanisms by
which LDOC1 induces apoptosis. At the same time, analyses
of the expression and modiﬁcation patterns of LDOC1 in var-
ious cancer tissues will help us to judge the usefulness of this
molecule as a diagnostic marker.
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